Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Working Capital Changes: 2013-2025

Historic Other Working Capital Changes for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $7.9 million.

  • Amphastar Pharmaceuticals' Other Working Capital Changes fell 25.99% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 2.05%. This contributed to the annual value of $10.7 million for FY2024, which is 1975222.28% up from last year.
  • Amphastar Pharmaceuticals' Other Working Capital Changes amounted to $7.9 million in Q3 2025, which was up 73.84% from $4.6 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Other Working Capital Changes high stood at $10.7 million for Q3 2024, and its period low was -$1.8 million during Q4 2021.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Other Working Capital Changes value was $635,000 (recorded in 2023), while the average stood at $2.4 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Other Working Capital Changes slumped by 5,695.30% in 2023 and then surged by 1,589.76% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$1.8 million in 2021, then skyrocketed by 282.32% to $3.2 million in 2022, then fell by 11.36% to $2.8 million in 2023, then plummeted by 91.63% to $237,000 in 2024, then fell by 25.99% to $7.9 million in 2025.
  • Its last three reported values are $7.9 million in Q3 2025, $4.6 million for Q2 2025, and $849,000 during Q1 2025.